Intuniv (guanfacine XR) / Shionogi, Takeda  >>  Phase 2
Welcome,         Profile    Billing    Logout  

4 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Intuniv (guanfacine XR) / Shionogi, Takeda
NCT04198116: Combining Varenicline and Guanfacine for Smoking Cessation

Recruiting
2
140
US
Varenicline, Chantix, Guanfacine ER, Intuniv
Yale University, National Institute on Drug Abuse (NIDA)
Smoking Cessation
08/24
08/24
NCT03764098: Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders

Recruiting
2
160
US
Guanfacine ER, Intuniv, Placebo
Yale University, National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Alcohol Use
02/25
02/26
NCT05273567: A Trial of Guanfacine-er for Cannabis Use Disorder

Active, not recruiting
2
90
US
guanfacine-ER, Intuniv-er, Placebo
New York State Psychiatric Institute, National Institute on Drug Abuse (NIDA)
Cannabis Use
03/25
03/25
GRACE, NCT05957848: Guanfacine Extended-release for Adolescents With Cannabis Use

Recruiting
2
100
RoW
Guanfacine Extended Release Oral Tablet, Intuniv, Guanfacine XR, Residential withdrawal, Engagement with alcohol and other drug services, Placebo
Orygen, Youth Support and Advocacy Service, University of Melbourne
Cannabis Use Disorder
12/25
06/26

Download Options